Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Subscribe To Our Newsletter & Stay Updated